𝐃𝐎𝐒𝐓'𝐬 𝐏𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐞 𝐔𝐬𝐞 𝐨𝐟 𝐈𝐯𝐞𝐫𝐦𝐞𝐜𝐭𝐢𝐧 𝐟𝐨𝐫 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐟 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗

Experts in the scientific and medical field have already spoken. In the case of the Department of Science and Technology (DOST), our most common involvement is the development of dia Experts in the scientific and medical field have already spoken. In the case of the Department of Science and Technology (DOST), our most common involvement is the development of diagnostic kits, disease models, drugs and adjunctive therapies which include clinical trials. gnostic kits, disease models, drugs and adjunctive therapies which include clinical trials.

Clinical trial projects will require a minimum of 6 months and can extend to years. That is how long we have to wait to have results and conclusions. Considering, however, that there are almost 20 completed and 40 ongoing clinical trials around the world as reported in clinicaltrials.gov exploring the use of Ivermectin formulations against COVID-19, the Philippine Council for Health Research and Development (DOST-PCHRD) is of the position that there is no need to conduct another clinical trial in the Philippines. 

As most ongoing clinical trials have already been implemented since 2020, it would be appropriate to await the results of these studies that are already significantly advanced in terms of data collection and conducting interim analyses.

#dostPH

#ScienceForThePeople